Otezla (apremilast)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Otezla (apremilast), covering 2024-01-05 to 2024-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. [Phase 4]